• LAST PRICE
    0.0550
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    ---/ ---
  • Ask / Lots
    ---/ ---
  • Open / Previous Close
    0.0000 / 0.0550
  • Day Range
    ---
  • 52 Week Range
    Low 0.0550
    High 0.1298
  • Volume
    ---

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
Table Data Not Available
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesKLYG
Kelyniam Global Inc
1.6M
-2.2x
---
United StatesSEQL
SeqLL Inc
1.5M
-0.2x
---
United StatesBRSF
Brain Scientific Inc
932.0K
-0.1x
---
United StatesABMT
Advanced Biomedical Technologies Inc
2.3M
-3.6x
---
United StatesKALO
Kallo Inc
1.9M
-2.1x
---
United StatesWCUI
Wellness Center USA Inc
46.2K
0.0x
---
As of 2024-02-22

Company Information

Kelyniam Global, Inc. is a custom design-to-build medical device manufacturing company. The Company specializes in the delivery of cranial implant technologies to neurologically dependent patients. The Company is engaged in the production of custom prosthetics utilizing computer-aided design and computer-aided manufacturing of medical-grade polymers. Its Engineering Division uses Bio-Computer Aided Design (CAD) Computer Aided Manufacturing (CAM) technology to provide replicated cranial implants to replace damaged bone structures. Its product, PEEK-Optima, is engineered for biocompatibility. Derived from the patient’s computed tomography (CT) data, the Company’s 3D BIO-CAD/CAM software is used to transfer the details found on the edge of the defect directly to the implant edge. Its K-Plans include ke24, ke72 and kp5day. The Company’s emergency plan, ke24, provides precision-replicated, patient-specific cranial implants in approximately 24 hours.

Contact Information

Headquarters
97 River RdCOLLINSVILLE, CT, United States 06019-3246
Phone
800-280-8192
Fax
501-641-2000

Executives

Chairman of the Board, Chief Executive Officer
Ross Bjella
Chief Financial Officer
Terrance Kurtenbach
Chief Operating Officer
Christopher Breault
Vice President - Sales and Marketing
Mark Chenoweth
Vice President - Sales and Business Development
Mark Smith

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$1.6M
Revenue (TTM)
$517.7K
Shares Outstanding
29.9M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
-1.48
EPS
$-0.03
Book Value
$0.00
P/E Ratio
-2.2x
Price/Sales (TTM)
3.2
Price/Cash Flow (TTM)
---
Operating Margin
-93.80%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.